MedPath

Fuzhou General Hospital

🇨🇳China
Ownership
-
Employees
-
Market Cap
-
Website

Compare Apatinib Plus Chemotherapy Drug Versus Chemotherapy Drug as Second-line Treatment in NSCLC

Phase 2
Terminated
Conditions
Nonsmall Cell Lung Cancer
Interventions
Drug: Apatinib/docetaxel/pemetrexed
Drug: docetaxel/pemetrexed
First Posted Date
2017-08-22
Last Posted Date
2021-02-08
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
37
Registration Number
NCT03256721
Locations
🇨🇳

Fuzhou general hospital, Fuzhou, Fujian, China

Clinical Study of Microchimerism and cfDNA as Biomarkers for Acute Rejection After Organ Transplantation

Conditions
Organ Transplant Rejection
Interventions
Other: no interventions
First Posted Date
2017-08-21
Last Posted Date
2017-08-21
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
950
Registration Number
NCT03255265
Locations
🇨🇳

Fuzhou General Hospital, Xiamen Univ Fuzhou, Fujian China, Fuzhou, Fujian, China

Effect of SVF Derived MSC in DCD Renal Transplantation

Phase 1
Conditions
Uremia
Interventions
Other: SVFderived MSC transplantations
First Posted Date
2015-07-08
Last Posted Date
2015-07-08
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
120
Registration Number
NCT02492490
Locations
🇨🇳

Fuzhou General Hospital, Xiamen Univ, Fuzhou, Fujian, China

Induction With SVF Derived MSC in Living-related Kidney Transplantation

Phase 1
Conditions
Living-relative Kidney Transplantation
Interventions
Procedure: SVF-MSC induction
First Posted Date
2015-07-08
Last Posted Date
2015-07-08
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
120
Registration Number
NCT02492308
Locations
🇨🇳

Xi er huan road No.156, Fuzhou, Fujian, China

Umbilical Cord Mesenchymal Stem Cell Treatment for Crohn's Disease

Phase 1
Completed
Conditions
Crohn Disease
Interventions
Other: UC-MSCs by peripheral intravenous infusion
Drug: received hormone maintenance therapy
First Posted Date
2015-05-15
Last Posted Date
2017-01-18
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
82
Registration Number
NCT02445547
Locations
🇨🇳

Shaanxi Provincial People's Hospital, Xi Ail, Shaanxi, China

Islet Transplantation Through an Indwelling Catheter in the Umbilical Vein

Phase 1
Completed
Conditions
Type 1 Diabetes Mellitus
Interventions
Procedure: umbilical vein catheterization
First Posted Date
2015-02-20
Last Posted Date
2015-02-20
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
12
Registration Number
NCT02367534

TDF and LdT in Immune-tolerant CHB Patients Awaiting Assisted Reproduction

Phase 1
Completed
Conditions
Hepatitis B, Chronic
Interventions
First Posted Date
2015-01-14
Last Posted Date
2018-09-24
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
121
Registration Number
NCT02338674
Locations
🇨🇳

Fuzhou General Hospital, Xiamen Univ, Fuzhou, Fujian, China

Plasmakinetic Enucleation of the Prostate and Open Prostatectomy to Treat Large Prostates

Not Applicable
Completed
Conditions
Benign Prostate Hyperplasia
Interventions
Procedure: OP
Procedure: PkEP
First Posted Date
2013-09-30
Last Posted Date
2013-09-30
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
160
Registration Number
NCT01952912
Locations
🇨🇳

Fuzhou General Hospital, Fuzhou, Fujian, China

MSC and MC in Type 2 Diabetes Mellitus

Phase 1
Completed
Conditions
Diabetes Mellitus, Type 2
Interventions
Drug: infusion of MSCs
Drug: infusion MCs
First Posted Date
2012-11-01
Last Posted Date
2023-01-12
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
22
Registration Number
NCT01719640
Locations
🇨🇳

Fuzhou General Hospital, Xiamen Univ, Fuzhou, Fujian, China

Plasmakinetic Enucleation of the Prostate to Treat Benign Prostatic Hypertrophy Patients With Large Prostate

Not Applicable
Completed
Conditions
BPH With Large Prostate
Interventions
Procedure: B-TURP
Procedure: PkEP
First Posted Date
2012-07-11
Last Posted Date
2012-07-11
Lead Sponsor
Fuzhou General Hospital
Target Recruit Count
80
Registration Number
NCT01637701
Locations
🇨🇳

Fuzhou General Hospital, Fuzhou, Fujian, China

© Copyright 2025. All Rights Reserved by MedPath